Adenocarcinoma of Unknown Primary
Associated Genetic Biomarkers
NCI Definition: An adenocarcinoma which has metastasized from an unknown primary anatomic site. 
There are 3 clinical trials for adenocarcinoma of unknown primary, of which 3 are open and 0 are completed or closed. Of the trials that contain adenocarcinoma of unknown primary as an inclusion criterion, 2 are phase 1 (2 open) and 1 is phase 2 (1 open).
Aldesleukin, autologous natural killer cell-like ctls, and bortezomib are the most common interventions in adenocarcinoma of unknown primary clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.